Literature DB >> 34120320

Sec62 promotes pro-angiogenesis of hepatocellular carcinoma cells under hypoxia.

Yongbin Meng1, Hetong Zhao1, Zhihao Zhao1, Zifei Yin1, Zhe Chen1, Juan Du2.   

Abstract

This study aimed to investigate the underlying molecular pathogenic mechanism of Sec62 in hepatocellular carcinoma (HCC). Microarray analysis was conducted to profile the global gene expression in the HCC cell line Huh7 cells transfected with Sec62high vs. NC and Sec62low vs. NC. Ingenuity pathway analysis and gene set enrichment analysis were used to perform Sec62-related signaling pathway analysis from screened differentially expressed genes (DEGs). A protein-protein interaction network was constructed. Experimental validation of the expression of key DEGs was conducted. Hypoxia-induced tube formation was undertaken to investigate the role of Sec62 in angiogenesis. A total of 74 intersected DEGs were identified from Huh7 cells with Sec62high vs. NC and Sec62low vs. NC. Among them, 65 DEGs were correlated with the expression of Sec62. The P53 signaling pathway was found to be enriched in Huh7 cells with Sec62high vs. NC, while the acute phase response signaling pathway was enriched in Huh7 cells with Sec62low vs. NC. DEGs, such as serine protease inhibitor E (SERPINE) and tumor necrosis factor receptor superfamily, member 11B (TNFRSF11B), were not only identified as the lead genes of these enriched pathways, but were also found to be closely related to Sec62. Moreover, knockdown of Sec62 decreased the expression of SERPINE1 (plasminogen activator inhibitor type 1 (PAI-1)) and TNFRSF11B, whereas overexpression of Sec62 had the opposite effects. In addition, knockdown of Sec62 inhibited hypoxia-induced tube formation via PAI-1. Sec62 promoted pro-angiogenesis of HCC under hypoxia by regulating PAI-1, and it may be a crucial angiogenic switch in HCC.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Angiogenesis; Hepatocellular carcinoma; Hypoxia; PAI-1; Sec62

Mesh:

Year:  2021        PMID: 34120320     DOI: 10.1007/s12013-021-01008-6

Source DB:  PubMed          Journal:  Cell Biochem Biophys        ISSN: 1085-9195            Impact factor:   2.194


  23 in total

1.  Rodent-specific hypoxia response elements enhance PAI-1 expression through HIF-1 or HIF-2 in mouse hepatoma cells.

Authors:  Yong-Tae Ahn; Mei-Sze Chua; James P Whitlock; Yong-Chil Shin; Woon-Heung Song; Yongkuk Kim; Chi-Yong Eom; Won Gun An
Journal:  Int J Oncol       Date:  2010-12       Impact factor: 5.650

2.  Exosomal miR-155 Derived from Hepatocellular Carcinoma Cells Under Hypoxia Promotes Angiogenesis in Endothelial Cells.

Authors:  Yusuke Matsuura; Hiroshi Wada; Hidetoshi Eguchi; Kunihito Gotoh; Shogo Kobayashi; Mitsuru Kinoshita; Masahiko Kubo; Koji Hayashi; Yoshifumi Iwagami; Daisaku Yamada; Tadafumi Asaoka; Takehiro Noda; Koichi Kawamoto; Yutaka Takeda; Masahiro Tanemura; Koji Umeshita; Yuichiro Doki; Masaki Mori
Journal:  Dig Dis Sci       Date:  2018-11-22       Impact factor: 3.199

3.  Assessment of efficacy and safety of the transcatheter arterial chemoembolization with or without apatinib in the treatment of large hepatocellular carcinoma.

Authors:  Juanfang Liu; Shanshan Xie; Xuhua Duan; Jianjian Chen; Xueliang Zhou; Yahua Li; Zhaonan Li; Xinwei Han
Journal:  Cancer Chemother Pharmacol       Date:  2019-12-07       Impact factor: 3.333

4.  Silencing of the SEC62 gene inhibits migratory and invasive potential of various tumor cells.

Authors:  Markus Greiner; Birgit Kreutzer; Volker Jung; Rainer Grobholz; Andrea Hasenfus; Robert Franz Stöhr; Luigi Tornillo; Johanna Dudek; Michael Stöckle; Gerhard Unteregger; Jörn Kamradt; Bernd Wullich; Richard Zimmermann
Journal:  Int J Cancer       Date:  2011-05-15       Impact factor: 7.396

Review 5.  The Role of Angiogenesis in Hepatocellular Carcinoma.

Authors:  Michael A Morse; Weijing Sun; Richard Kim; Aiwu Ruth He; Paolo B Abada; Michelle Mynderse; Richard S Finn
Journal:  Clin Cancer Res       Date:  2018-10-01       Impact factor: 12.531

6.  HIF-2alpha-dependent PAI-1 induction contributes to angiogenesis in hepatocellular carcinoma.

Authors:  Theresa Geis; Claudia Döring; Rüdiger Popp; Nina Grossmann; Ingrid Fleming; Martin-Leo Hansmann; Nathalie Dehne; Bernhard Brüne
Journal:  Exp Cell Res       Date:  2014-12-06       Impact factor: 3.905

7.  Genomic and expression analysis of the 3q25-q26 amplification unit reveals TLOC1/SEC62 as a probable target gene in prostate cancer.

Authors:  Volker Jung; Roland Kindich; Jörn Kamradt; Martin Jung; Mirko Müller; Wolfgang A Schulz; Rainer Engers; Gerhard Unteregger; Michael Stöckle; Richard Zimmermann; Bernd Wullich
Journal:  Mol Cancer Res       Date:  2006-03       Impact factor: 5.852

8.  Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.

Authors:  Lisa D Sprague; Herbert Tomaso; Karin Mengele; Daniela Schilling; Christine Bayer; Peter Stadler; Manfred Schmitt; Michael Molls
Journal:  Oncol Rep       Date:  2007-05       Impact factor: 3.906

9.  AtSec62 is critical for plant development and is involved in ER-phagy in Arabidopsis thaliana.

Authors:  Shuai Hu; Hao Ye; Yong Cui; Liwen Jiang
Journal:  J Integr Plant Biol       Date:  2019-11-19       Impact factor: 7.061

10.  Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: a clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells.

Authors:  Maximilian Linxweiler; Stefan Schorr; Nico Schäuble; Martin Jung; Johannes Linxweiler; Frank Langer; Hans-Joachim Schäfers; Adolfo Cavalié; Richard Zimmermann; Markus Greiner
Journal:  BMC Cancer       Date:  2013-12-05       Impact factor: 4.430

View more
  2 in total

Review 1.  The endoplasmic reticulum membrane protein Sec62 as potential therapeutic target in SEC62 overexpressing tumors.

Authors:  Julia S M Zimmermann; Johannes Linxweiler; Julia C Radosa; Maximilian Linxweiler; Richard Zimmermann
Journal:  Front Physiol       Date:  2022-10-03       Impact factor: 4.755

Review 2.  ER-phagy in the Occurrence and Development of Cancer.

Authors:  Huimin Zhou; Kexin Wang; Mengyan Wang; Wenxia Zhao; Conghui Zhang; Meilian Cai; Yuhan Qiu; Tianshu Zhang; Rongguang Shao; Wuli Zhao
Journal:  Biomedicines       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.